177 related articles for article (PubMed ID: 1992596)
1. Prognostic factors and value of adjunctive nephrectomy in patients with stage IV renal cell carcinoma.
Naito S; Kimiya K; Sakamoto N; Soejima T; Ueda T; Kumazawa J; Osada Y; Kurozumi T; Sagiyama K; Ariyoshi A
Urology; 1991 Feb; 37(2):95-9. PubMed ID: 1992596
[TBL] [Abstract][Full Text] [Related]
2. Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma.
Vasselli JR; Yang JC; Linehan WM; White DE; Rosenberg SA; Walther MM
J Urol; 2001 Jul; 166(1):68-72. PubMed ID: 11435825
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors and the role of nephrectomy in metastatic renal cell carcinoma.
Uygur MC; Usubütün A; Ozen H; Ayhan A; Kendi S
Int Urol Nephrol; 1998; 30(6):681-7. PubMed ID: 10195860
[TBL] [Abstract][Full Text] [Related]
4. Metastatic renal cell carcinoma with concurrent inferior vena caval invasion: long-term survival after combination therapy with radical nephrectomy, vena caval thrombectomy and postoperative immunotherapy.
Naitoh J; Kaplan A; Dorey F; Figlin R; Belldegrun A
J Urol; 1999 Jul; 162(1):46-50. PubMed ID: 10379737
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors in metastatic renal carcinoma.
Maldazys JD; deKernion JB
J Urol; 1986 Aug; 136(2):376-9. PubMed ID: 3735498
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors and the role of nephrectomy in metastatic renal cell carcinoma.
Uygur MC; Usubütün A; Ozen H; Ayhan A; Kendi S
J Exp Clin Cancer Res; 1999 Sep; 18(3):397-401. PubMed ID: 10606187
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of Patients with Renal Cell Carcinoma and Sarcomatoid Dedifferentiation Treated with Nephrectomy and Systemic Therapies: Comparison between the Cytokine and Targeted Therapy Eras.
Keskin SK; Msaouel P; Hess KR; Yu KJ; Matin SF; Sircar K; Tamboli P; Jonasch E; Wood CG; Karam JA; Tannir NM
J Urol; 2017 Sep; 198(3):530-537. PubMed ID: 28411072
[TBL] [Abstract][Full Text] [Related]
8. Factors of importance for prediction of survival in patients with metastatic renal cell carcinoma, treated with or without nephrectomy.
Ljungberg B; Landberg G; Alamdari FI
Scand J Urol Nephrol; 2000 Aug; 34(4):246-51. PubMed ID: 11095082
[TBL] [Abstract][Full Text] [Related]
9. Clinical study of brain metastasis of renal cell carcinoma.
Harada Y; Nonomura N; Kondo M; Nishimura K; Takahara S; Miki T; Okuyama A
Eur Urol; 1999 Sep; 36(3):230-5. PubMed ID: 10450008
[TBL] [Abstract][Full Text] [Related]
10. Cytoreductive nephrectomy with thrombectomy before targeted therapy improves survival for metastatic renal cell carcinoma with venous tumor thrombus: a single-center experience.
Qi N; Wu P; Chen J; Li T; Ning X; Wang J; Gong K
World J Surg Oncol; 2017 Jan; 15(1):4. PubMed ID: 28056988
[TBL] [Abstract][Full Text] [Related]
11. Stage IV renal cell carcinoma.
Frank W; Stuhldreher D; Saffrin R; Shott S; Guinan P
J Urol; 1994 Dec; 152(6 Pt 1):1998-9. PubMed ID: 7966660
[TBL] [Abstract][Full Text] [Related]
12. [Treatment and prognosis of T 4 renal cell carcinoma].
Fukuda M; Satomi Y; Nakahashi M; Senga Y; Oogo Y; Udagawa K; Asakura T
Nihon Hinyokika Gakkai Zasshi; 1999 Sep; 90(9):753-62. PubMed ID: 10517083
[TBL] [Abstract][Full Text] [Related]
13. Metastatic renal cell carcinoma risk according to tumor size.
Thompson RH; Hill JR; Babayev Y; Cronin A; Kaag M; Kundu S; Bernstein M; Coleman J; Dalbagni G; Touijer K; Russo P
J Urol; 2009 Jul; 182(1):41-5. PubMed ID: 19450840
[TBL] [Abstract][Full Text] [Related]
14. Characteristics and prognosis of chromophobe non-metastatic renal cell carcinoma: a multicenter study.
Lee WK; Byun SS; Kim HH; Rha KH; Hwang TK; Sung GT; Lee W; Lim JS; Jeong YB; Kwon TG
Int J Urol; 2010 Nov; 17(11):898-904. PubMed ID: 20969636
[TBL] [Abstract][Full Text] [Related]
15. [Factors influencing the prognosis of grade 1 renal cell carcinoma].
Igarashi T; Murakami S; Tomioka S; Abe K; Isaka S; Okano T; Masai M; Shimazaki J; Matsuzaki O
Nihon Hinyokika Gakkai Zasshi; 1989 Feb; 80(2):264-9. PubMed ID: 2747090
[TBL] [Abstract][Full Text] [Related]
16. Metastatic renal cell carcinoma (RCC): spontaneous regression, long-term survival and late recurrence.
de Riese W; Goldenberg K; Allhoff E; Stief C; Schlick R; Liedke S; Jonas U
Int Urol Nephrol; 1991; 23(1):13-25. PubMed ID: 1938215
[TBL] [Abstract][Full Text] [Related]
17. Clinical Impact of Pancreatic Metastases from Renal Cell Carcinoma: A Multicenter Retrospective Analysis.
Grassi P; Doucet L; Giglione P; Grünwald V; Melichar B; Galli L; De Giorgi U; Sabbatini R; Ortega C; Santoni M; Bamias A; Verzoni E; Derosa L; Studentova H; Pacifici M; Coppa J; Mazzaferro V; de Braud F; Porta C; Escudier B; Procopio G
PLoS One; 2016; 11(4):e0151662. PubMed ID: 27064898
[TBL] [Abstract][Full Text] [Related]
18. Solitary metastases from renal cell carcinoma: a review.
Tongaonkar HB; Kulkarni JN; Kamat MR
J Surg Oncol; 1992 Jan; 49(1):45-8. PubMed ID: 1548881
[TBL] [Abstract][Full Text] [Related]
19. Predictors of survival of advanced renal cell carcinoma: long-term results from Southwest Oncology Group Trial S8949.
Lara PN; Tangen CM; Conlon SJ; Flanigan RC; Crawford ED;
J Urol; 2009 Feb; 181(2):512-6; discussion 516-7. PubMed ID: 19100570
[TBL] [Abstract][Full Text] [Related]
20. [Influential clinical and pathological factors on prognosis of renal cell carcinoma].
Saika T; Yamamoto Y; Takeda K; Asahi T
Hinyokika Kiyo; 1994 Mar; 40(3):189-93. PubMed ID: 7513936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
